Researchers Submit Patent Application, 'Il-2rbeta-Selective Agonists In Combination With An Anti-Ctla-4 Antibody Or An Anti-Pd-1 Antibody', for Approval (USPTO 20200368321)

Source :: Women's Health Weekly. December 17, 2020, 1183
Publication Year :: 2020
Abstract: 2020 DEC 17 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors Addepalli, [...]

Subjects :: Nektar Therapeutics -- Intellectual property
Interleukins -- Intellectual property
Women's health
Biotechnology industries -- Intellectual property
Palladium -- Intellectual property
Antibodies
Health
Women's issues/gender studies

Tools